New Alzheimer’s drug holds promise but adds cost pressures for Medicare
retirementrevised.substack.com
Federal officials gave the green light last week to an expensive new drug that may be able to slow the advance of Alzheimer’s disease - a decision that might sound like a repeat of a story you’ve already read about soaring Medicare premiums and controversy over drug effectiveness.
New Alzheimer’s drug holds promise but adds cost pressures for Medicare
New Alzheimer’s drug holds promise but adds…
New Alzheimer’s drug holds promise but adds cost pressures for Medicare
Federal officials gave the green light last week to an expensive new drug that may be able to slow the advance of Alzheimer’s disease - a decision that might sound like a repeat of a story you’ve already read about soaring Medicare premiums and controversy over drug effectiveness.